GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Auxilium Pharmaceuticals, Inc. (AUXL) [hlAlert]

Rating:
Buy AUXL
up 95.54 %

Auxilium Pharmaceuticals, Inc. (AUXL) rated Buy with price target $39 by Canaccord Genuity

Posted on: Monday,  Mar 3, 2014  10:25 AM ET by Canaccord Genuity

Canaccord Genuity rated Buy Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) on 03/03/2014. Previously Canaccord Genuity rated Buy Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) on
03/26/2012., when the stock price was $18.65. Since then, Auxilium Pharmaceuticals, Inc. has gained 95.55% as of 01/29/2015's recent price of $36.47.
If you would have followed the previous Canaccord Genuity's recommendation on AUXL, you would have gained 95.54% of your investment in 1039 days.

Auxilium Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets products for urology and sexual health. Auxilium markets Testim 1%, a topical testosterone gel, for the treatment of hypogonadism. Auxilium is developing additional Testim line extensions, as well as other products for urology and sexual health, including an enzyme in Phase II for the treatment of Peyronie's Disease that may also prove useful for the treatment of Dupuytren's Disease.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/3/2014 10:25 AM Buy
None
30.45 39.00
as of 10/17/2014
1 Week down  -3.58 %
1 Month down  -1.76 %
3 Months up  58.29 %
1 YTD up  47.75 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/30/2013 12:25 PM Buy
None
14.70 20.00
3/26/2012 9:25 AM Buy
None
18.65 26.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy